Introduction
Despite the current uncertainty in equity markets, the pharmaceutical industry has remained relatively stable, thanks to the consistent and growing demand for the products pharma companies produce. The global pharmaceutical market is expected to grow at a 15.9% CAGR from 2022 to 2030, reaching $1.599T by 2030.1 The existing industry leaders are projected to retain and gain share as patents protect their existing intellectual property and companies continue to develop new drugs and vaccines. This blog intends to answer frequently asked questions on the pharmaceutical industry and, more specifically, VacEck’s Pharmaceutical ETF (PPH).
What is the general outlook for the pharmaceutical industry?
The pharmaceutical sector’s growth has largely been attributed to new, proprietary drug development and rising demand for healthcare.
Between 2008 and 2012, 28 new drugs…